A novel peptide specifically binding to VEGF receptor suppresses angiogenesis and (Q56890125)

2

0 references

Kun Liu

3

0 references

Lin Ning

4

0 references

Delun Luo

5

0 references

Kai Xu

6

0 references

Wenli Zhu

7

0 references

Zhigang Wu

8

0 references

Jian Huang

9

0 references

Xun Xu

Signal Transduction and Targeted Therapy

10

0 references

language of work or name

English

0 references

publication date

2017

0 references

published in

0 references

volume

2

0 references

page(s)

17010

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

12 May 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Introduction: Understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Angiogenesis in life, disease and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Ten years of anti-vascular endothelial growth factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

The future of peptide-based drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

A promising future for peptides in ophthalmology: work effectively and smartly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Phage display as a technology delivering on the promise of peptide drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Biopanning and rapid analysis of selective interactive ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

VEGF-Trap: a VEGF blocker with potent antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Anti-Angiogenic and Anti-Inflammatory Effects of SERPINA3K on Corneal Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Inhibition of Pathologic Corneal Neovascularization by Topical Application of a Novel Peptide In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

BDB: biopanning data bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

MimoDB 2.0: a mimotope database and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

MimoDB: a new repository for mimotope data derived from phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Bioinformatics resources and tools for phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

The nature of target-unrelated peptides recovered in the screening of phage-displayed random peptide libraries with antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Phage display: selecting straws instead of a needle from a haystack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Antiangiogenic cancer therapy: why do mouse and human patients respond in a different way to the same drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

The angiogenic inhibitor TNP-470 decreases caloric intake and weight gain in high-fat fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

The anti-angiogenic herbal extract from Melissa officinalis inhibits adipogenesis in 3T3-L1 adipocytes and suppresses adipocyte hypertrophy in high fat diet-induced obese C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Reduction of Adipose Tissue Mass by the Angiogenesis Inhibitor ALS-L1023 from Melissa officinalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Korean red ginseng (Panax ginseng) prevents obesity by inhibiting angiogenesis in high fat diet-induced obese C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

SABinder: A Web Service for Predicting Streptavidin-Binding Peptides.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

Tumor refractoriness to anti-VEGF therapy

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

Profile of conbercept in the treatment of neovascular age-related macular degeneration

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

Phage display informatics

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

Epitope mapping of metuximab on CD147 using phage display and molecular docking.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

SVSVGMKPSPRP: a broad range adhesion peptide

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

Forty-year journey of angiogenesis translational research

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

SAROTUP: scanner and reporter of target-unrelated peptides

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

Automated detection of conformational epitopes using phage display Peptide sequences

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5661615

Retinopathy of prematurity

2 November 2018

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

inferred from DOI database lookup

7 January 2021

based on heuristic

The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10

inferred from DOI database lookup

7 January 2021

based on heuristic

A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038/SIGTRANS.2017.10